← Open Payments lookup

JUDITH AKOH-ARREY: Open Payments

NPI 1699336651 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$647 in 31 payments from 10 companies in 2025. Trend: 2023 $416 · 2024 $589 · 2025 $647

Food & beverage: $647
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$116
Lundbeck LLC5$111
Teva Pharmaceuticals USA, Inc.4$109
ABBVIE INC.6$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
Otsuka America Pharmaceutical, Inc.3$50
Takeda Pharmaceuticals U.S.A., Inc.2$41
Axsome Therapeutics, Inc.2$36
Janssen Pharmaceuticals, Inc1$14
TMS NeuroHealth Centers Inc.1$13

Products named: REXULTI, INGREZZA, UZEDY, VRAYLAR, CAPLYTA, TRINTELLIX, Auvelity, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.